125 related articles for article (PubMed ID: 26518893)
1. The Notch signaling pathway in esophageal adenocarcinoma.
Wang Z; Chen J; Capobianco AJ
Cell Mol Biol (Noisy-le-grand); 2015 Oct; 61(6):24-32. PubMed ID: 26518893
[TBL] [Abstract][Full Text] [Related]
2. Blocking the NOTCH pathway can inhibit the growth of CD133-positive A549 cells and sensitize to chemotherapy.
Liu J; Mao Z; Huang J; Xie S; Liu T; Mao Z
Biochem Biophys Res Commun; 2014 Feb; 444(4):670-5. PubMed ID: 24502949
[TBL] [Abstract][Full Text] [Related]
3. Dysfunctional transforming growth factor-β signaling with constitutively active Notch signaling in Barrett's esophageal adenocarcinoma.
Mendelson J; Song S; Li Y; Maru DM; Mishra B; Davila M; Hofstetter WL; Mishra L
Cancer; 2011 Aug; 117(16):3691-702. PubMed ID: 21305538
[TBL] [Abstract][Full Text] [Related]
4. Conversion of metaplastic Barrett's epithelium into post-mitotic goblet cells by gamma-secretase inhibition.
Menke V; van Es JH; de Lau W; van den Born M; Kuipers EJ; Siersema PD; de Bruin RW; Kusters JG; Clevers H
Dis Model Mech; 2010; 3(1-2):104-10. PubMed ID: 20075383
[TBL] [Abstract][Full Text] [Related]
5. Notch signaling drives stemness and tumorigenicity of esophageal adenocarcinoma.
Wang Z; Da Silva TG; Jin K; Han X; Ranganathan P; Zhu X; Sanchez-Mejias A; Bai F; Li B; Fei DL; Weaver K; Carpio RV; Moscowitz AE; Koshenkov VP; Sanchez L; Sparling L; Pei XH; Franceschi D; Ribeiro A; Robbins DJ; Livingstone AS; Capobianco AJ
Cancer Res; 2014 Nov; 74(21):6364-74. PubMed ID: 25164006
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of Notch pathway by a gamma-secretase inhibitor attenuates AKT/mammalian target of rapamycin signaling and glucose uptake in an ERBB2 transgenic breast cancer model.
Efferson CL; Winkelmann CT; Ware C; Sullivan T; Giampaoli S; Tammam J; Patel S; Mesiti G; Reilly JF; Gibson RE; Buser C; Yeatman T; Coppola D; Winter C; Clark EA; Draetta GF; Strack PR; Majumder PK
Cancer Res; 2010 Mar; 70(6):2476-84. PubMed ID: 20197467
[TBL] [Abstract][Full Text] [Related]
7. Curcumin induces cell death in esophageal cancer cells through modulating Notch signaling.
Subramaniam D; Ponnurangam S; Ramamoorthy P; Standing D; Battafarano RJ; Anant S; Sharma P
PLoS One; 2012; 7(2):e30590. PubMed ID: 22363450
[TBL] [Abstract][Full Text] [Related]
8. Dysfunctional transforming growth factor-β signaling with constitutively active notch signaling in Barrett's esophageal adenocarcinoma.
Masuda S
Cancer; 2012 Apr; 118(7):1956-7; author reply 1957-8. PubMed ID: 21898377
[No Abstract] [Full Text] [Related]
9. Notch signaling drives development of Barrett's metaplasia from Dclk1-positive epithelial tuft cells in the murine gastric mucosa.
Kunze B; Middelhoff M; Maurer HC; Agibalova T; Anand A; Bührer AM; Fang HY; Baumeister T; Steiger K; Strangmann J; Schmid RM; Wang TC; Quante M
Sci Rep; 2021 Feb; 11(1):4509. PubMed ID: 33627749
[TBL] [Abstract][Full Text] [Related]
10. Notch signaling is inactive but inducible in human embryonic stem cells.
Noggle SA; Weiler D; Condie BG
Stem Cells; 2006 Jul; 24(7):1646-53. PubMed ID: 16614005
[TBL] [Abstract][Full Text] [Related]
11. Notch signaling, gamma-secretase inhibitors, and cancer therapy.
Shih IeM; Wang TL
Cancer Res; 2007 Mar; 67(5):1879-82. PubMed ID: 17332312
[TBL] [Abstract][Full Text] [Related]
12. Alterations of the Wnt signaling pathway during the neoplastic progression of Barrett's esophagus.
Clément G; Braunschweig R; Pasquier N; Bosman FT; Benhattar J
Oncogene; 2006 May; 25(21):3084-92. PubMed ID: 16407829
[TBL] [Abstract][Full Text] [Related]
13. Small molecules that inhibit Notch signaling.
De Kloe GE; De Strooper B
Methods Mol Biol; 2014; 1187():311-22. PubMed ID: 25053499
[TBL] [Abstract][Full Text] [Related]
14. Transient gamma-secretase inhibition accelerates and enhances fracture repair likely via Notch signaling modulation.
Wang C; Shen J; Yukata K; Inzana JA; O'Keefe RJ; Awad HA; Hilton MJ
Bone; 2015 Apr; 73():77-89. PubMed ID: 25527421
[TBL] [Abstract][Full Text] [Related]
15. Suppression of the notch signaling pathway by γ-secretase inhibitor GSI inhibits human nasopharyngeal carcinoma cell proliferation.
Chen SM; Liu JP; Zhou JX; Chen C; Deng YQ; Wang Y; Tao ZZ
Cancer Lett; 2011 Jul; 306(1):76-84. PubMed ID: 21420785
[TBL] [Abstract][Full Text] [Related]
16. Conjugated Bile Acids Promote Invasive Growth of Esophageal Adenocarcinoma Cells and Cancer Stem Cell Expansion via Sphingosine 1-Phosphate Receptor 2-Mediated Yes-Associated Protein Activation.
Liu R; Li X; Hylemon PB; Zhou H
Am J Pathol; 2018 Sep; 188(9):2042-2058. PubMed ID: 29963993
[TBL] [Abstract][Full Text] [Related]
17. Notch signaling in breast cancer and tumor angiogenesis: cross-talk and therapeutic potentials.
Shi W; Harris AL
J Mammary Gland Biol Neoplasia; 2006 Jan; 11(1):41-52. PubMed ID: 16947085
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms and clinical prospects of Notch inhibitors in the therapy of hematological malignancies.
Nefedova Y; Gabrilovich D
Drug Resist Updat; 2008 Dec; 11(6):210-8. PubMed ID: 18951834
[TBL] [Abstract][Full Text] [Related]
19. Activation of NOTCH signaling via DLL1 is mediated by APE1-redox-dependent NF-κB activation in oesophageal adenocarcinoma.
Chen L; Lu H; Peng D; Cao LL; Ballout F; Srirmajayam K; Chen Z; Bhat A; Wang TC; Capobianco A; Que J; McDonald OG; Zaika A; Zhang S; El-Rifai W
Gut; 2023 Mar; 72(3):421-432. PubMed ID: 35750470
[TBL] [Abstract][Full Text] [Related]
20. New insights into Notch1 regulation of the PI3K-AKT-mTOR1 signaling axis: targeted therapy of γ-secretase inhibitor resistant T-cell acute lymphoblastic leukemia.
Hales EC; Taub JW; Matherly LH
Cell Signal; 2014 Jan; 26(1):149-61. PubMed ID: 24140475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
